Ex vivo expansion of human mesenchymal stem cells: A more effective cell proliferation kinetics and metabolism under hypoxia

Journal of Cellular Physiology

Volumn 223, Issue 1, 2010, Pages 27-35

  Dos Santos, Francisco ^a   Andrade, Pedro Z ^a   Boura, Joana S ^a   Abecasis, Manuel M ^b   Da Silva, Cláudia Lobato ^a   Cabral, Joaquim M S ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL KINETICS; CELL LABELING; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; OXYGEN TENSION; PRIORITY JOURNAL; STEM CELL EXPANSION;

AMMONIA; CELL HYPOXIA; CELL PROLIFERATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; GLUCOSE; GLUTAMINE; HUMANS; KINETICS; LACTIC ACID; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; OXYGEN; PHENOTYPE;

EID: 75749145078     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.21987     Document Type: Article

References (36)

1. Acosta ML, Sanchez A, Garcia F, Contreras A, Molina E. 2007. Analysis of kinetic, stoichiometry and regulation of glucose and glutamine metabolism in hybridoma batch cultures using logistic equations. Cytotechnology 54:189-200.
2. Ball SG, Shuttleworth AC, Kielty CM. 2004. Direct cell contact influences bone marrow mesenchymal stem cell fate. Int J Biochem Cell Biol 36:714-727.
3. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. 2004. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682.
4. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. 2006. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7:14.
5. Caplan AI. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213:341-347.
6. Choi SC, Kim SJ, Choi JH, Park CY, Shim WJ, Lim DS. 2008. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrowmesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Stem Cells Dev 17:725-736.
7. Chow DC, Wenning LA, Miller WM, Papoutsakis ET. 2001. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 81:685-696.
8. Colter DC, Sekiya I, Prockop DJ. 2001. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA 98:7841-7845.
9. da Silva CL, Goncalves R, Porada CD, Ascensao JL, Zanjani ED, Cabral JM, Almeida-Porada G. 2009. Differences amid bone marrow and cord blood hematopoietic stem/progenitor cell division kinetics. J Cell Physiol 220:102-111.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
11. Follmar KE, Decroos FC, Prichard HL, Wang HT, Erdmann D, Olbrich KC. 2006. Effects of glutamine, glucose, and oxygen concentration on the metabolism and proliferation of rabbit adipose-derived stem cells. Tissue Eng 12:3525-3533.
12. Gódia F, Cairó JJ. 2006. Cell metabolism. In: Ozturk SS, Hu W, editors. Cell culture technology for pharmaceutical and cell-based therapies. Florida: CRC Press. pp. 81-112.
13. Grayson WL, Zhao F, Izadpanah R, Bunnell B, Ma T. 2006. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 207:331-339.
14. Grayson WL, Zhao F, Bunnell B, Ma T. 2007. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358:948-953.
15. Gregory CA, Singh H, Perry AS, Prockop DJ. 2003. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278:28067-28078.
16. Higuera G, Schop D, Janssen F, van Dijkhuizen-Radersma R, van Boxtel T, van Blitterswijk CA. 2009. Quantifying in vitro growth and metabolism kinetics of human mesenchymal stem cells using a mathematical model. Tissue Eng Part A 15:1877-1886.
17. Jones BJ, McTaggart SJ. 2008. Immunosuppression by mesenchymal stromal cells: From culture to clinic. Exp Hematol 36:733-741.
18. Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J, Devetten M, Jansen J, Herzig R, Schuster M, Monroy R, Uberti J. 2009. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Blood Marrow Transplant 15:804-811.
19. Kim J, Kang JW, Park JH, Choi Y, Choi KS, Park KD, Baek DH, Seong SK, Min HK, Kim HS. 2009. Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 32:117-126.
20. Kirouac DC, Zandstra PW. 2008. The systematic production of cells for cell therapies. Cell Stem Cell 3:369-381.
21. Le Blanc K, Ringden O. 2007. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262:509-525.
22. Neermann J, Wagner R. 1996. Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 166:152-169.
23. Ozturk SS, Thrift JC, Blackie JD,Naveh D. 1997. Real-time monitoring and control of glucose and lactate concentrations in a mammalian cell perfusion reactor. Biotechnol Bioeng 53:372-378.
24. Park JS, Chu JS, Cheng C, Chen F, Chen D, Li S. 2004. Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng 88: 359-368.
25. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H. 2007. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13:1325-1331.
26. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. 2006.
27. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397.
28. Rosova I, Dao M, Capoccia B, Link D, Nolta JA. 2008. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182.
29. Schop D, Janssen FW, van Rijn LD, Fernandes H, Bloem RM, de Bruijn JD, van Dijkhuizen-Radersma R. 2009. Growth, metabolism, and growth inhibitors of mesenchymal stem cells. Tissue Eng Part A 15: 2653-2663.
30. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. 2006. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24:462-471.
31. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926.
32. Subbanna PK. 2007. Mesenchymal stem cells for treating GVHD: In vivo fate and optimal dose. Med Hypotheses 69:469-470.
33. Tae SK, Lee SH, Park JS, Im GI. 2006. Mesenchymal stem cells for tissue engineering and regenerative medicine. Biomed Mater 1:63-71.
34. Vander Heiden, MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324:1029-1033.
35. Wang DW, Fermor B, Gimble JM, Awad HA, Guilak F. 2005. Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells. J Cell Physiol 204:184-191.
36. Zhu W, Chen J, Cong X, Hu S, Chen X. 2006. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24:416-425.